FABP4 and non-small cell lung carcinoma: Moreover, macro_FABP4 alveolar macrophages were reported to be significantly elevated in post-treatment NSCLC patients who received neoadjuvant PD-1 blockade combined with chemotherapy (Hu et al., 2023).